BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 15010115)

  • 1. F-18-FDG uptake is a reliable predictory of functional recovery of akinetic but viable infarct regions as defined by magnetic resonance imaging before and after revascularization.
    Schmidt M; Voth E; Schneider CA; Theissen P; Wagner R; Baer FM; Schicha H
    Magn Reson Imaging; 2004 Feb; 22(2):229-36. PubMed ID: 15010115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.
    Baer FM; Voth E; Schneider CA; Theissen P; Schicha H; Sechtem U
    Circulation; 1995 Feb; 91(4):1006-15. PubMed ID: 7850935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization.
    Baer FM; Voth E; Deutsch HJ; Schneider CA; Horst M; de Vivie ER; Schicha H; Erdmann E; Sechtem U
    J Am Coll Cardiol; 1996 Jul; 28(1):60-9. PubMed ID: 8752795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization.
    Baer FM; Theissen P; Schneider CA; Voth E; Sechtem U; Schicha H; Erdmann E
    J Am Coll Cardiol; 1998 Apr; 31(5):1040-8. PubMed ID: 9562005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability.
    Baer FM; Voth E; LaRosée K; Schneider CA; Theissen P; Deutsch HJ; Schicha H; Erdmann E; Sechtem U
    Am J Cardiol; 1996 Aug; 78(4):415-9. PubMed ID: 8752185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose dobutamine electrocardiograph-gated myocardial SPECT for identifying viable myocardium: comparison with dobutamine stress echocardiography and PET.
    Yoshinaga K; Morita K; Yamada S; Komuro K; Katoh C; Ito Y; Kuge Y; Kohya T; Kitabatake A; Tamaki N
    J Nucl Med; 2001 Jun; 42(6):838-44. PubMed ID: 11390545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of left ventricular functional recovery by dobutamine echocardiography, F-18 deoxyglucose or 99mTc sestamibi nuclear imaging in patients with chronic myocardial infarction.
    Lund GK; Freyhoff J; Schwaiger M; Lübeck M; Lund CH; Buchert R; Sheehan FH; Meinertz T; Nienaber CA
    Cardiology; 2002; 98(4):202-9. PubMed ID: 12566650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of viable myocardium by dobutamine transesophageal echocardiography and comparison with fluorine-18 fluorodeoxyglucose positron emission tomography.
    Baer FM; Voth E; Deutsch HJ; Schneider CA; Schicha H; Sechtem U
    J Am Coll Cardiol; 1994 Aug; 24(2):343-53. PubMed ID: 8034866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose dobutamine stress gated SPET for identification of viable myocardium: comparison with stress-rest perfusion SPET and PET.
    Yoshinaga K; Katoh C; Noriyasu K; Yamada S; Ito Y; Kuge Y; Kawai Y; Kohya T; Kitabatake A; Tamaki N
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):882-90. PubMed ID: 12111128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance: relation to functional outcome after revascularization.
    Knuesel PR; Nanz D; Wyss C; Buechi M; Kaufmann PA; von Schulthess GK; Lüscher TF; Schwitter J
    Circulation; 2003 Sep; 108(9):1095-100. PubMed ID: 12939229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET/MRI early after myocardial infarction: evaluation of viability with late gadolinium enhancement transmurality vs. 18F-FDG uptake.
    Rischpler C; Langwieser N; Souvatzoglou M; Batrice A; van Marwick S; Snajberk J; Ibrahim T; Laugwitz KL; Nekolla SG; Schwaiger M
    Eur Heart J Cardiovasc Imaging; 2015 Jun; 16(6):661-9. PubMed ID: 25680385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dobutamine-stress electrocardiographically gated positron emission tomography for detection of viable but dysfunctional myocardium.
    Yamagishi H; Akioka K; Hirata K; Sakanoue Y; Toda I; Yoshiyama M; Teragaki M; Takeuchi K; Yoshikawa J; Ochi H
    J Nucl Cardiol; 1999; 6(6):626-32. PubMed ID: 10608590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of recovery of left ventricular dysfunction after acute myocardial infarction: comparison between 99mTc-sestamibi cardiac tomography and low-dose dobutamine echocardiography.
    Spinelli L; Petretta M; Cuocolo A; Nicolai E; Acampa W; Vicario L; Bonaduce D
    J Nucl Med; 1999 Oct; 40(10):1683-92. PubMed ID: 10520709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dobutamine magnetic resonance imaging predicts contractile reserve of chronically dysfunctional myocardium: comparison with was fluorine-18 fluorodeoxyglucose positron emission tomography.
    Zhao S; Liu S; Janier M; Croisille P; Roux JP; Revel D
    Chin Med Sci J; 2000 Mar; 15(1):29-34. PubMed ID: 12899396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between contractile reserve and positron emission tomographic patterns of perfusion and glucose utilization in chronic ischemic left ventricular dysfunction: implications for identification of myocardial viability.
    Mélon PG; de Landsheere CM; Degueldre C; Peters JL; Kulbertus HE; Piérard LA
    J Am Coll Cardiol; 1997 Dec; 30(7):1651-9. PubMed ID: 9385890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization.
    Knuuti MJ; Saraste M; Nuutila P; Härkönen R; Wegelius U; Haapanen A; Bergman J; Haaparanta M; Savunen T; Voipio-Pulkki LM
    Am Heart J; 1994 Apr; 127(4 Pt 1):785-96. PubMed ID: 8154416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of myocardial viability in asymptomatic patients early after infarction with perfusion/metabolism single-photon-emission computed tomographic imaging and dobutamine echocardiography.
    Dangas G; Machac J; Goldman ME; Sharma SK; Shao JH; Cohen AM; Meraj P; Feldman D; Ambrose JA
    Coron Artery Dis; 2000 Jul; 11(5):409-14. PubMed ID: 10895407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.
    Rischpler C; Dirschinger RJ; Nekolla SG; Kossmann H; Nicolosi S; Hanus F; van Marwick S; Kunze KP; Meinicke A; Götze K; Kastrati A; Langwieser N; Ibrahim T; Nahrendorf M; Schwaiger M; Laugwitz KL
    Circ Cardiovasc Imaging; 2016 Apr; 9(4):e004316. PubMed ID: 27056601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.